BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 26108864)

  • 1. When folic acid fails: Insights from 20 years of neural tube defect surveillance in South Carolina.
    Bupp CP; Sarasua SM; Dean JH; Stevenson RE
    Am J Med Genet A; 2015 Oct; 167A(10):2244-50. PubMed ID: 26108864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decline in prevalence of neural tube defects in a high-risk region of the United States.
    Stevenson RE; Allen WP; Pai GS; Best R; Seaver LH; Dean J; Thompson S
    Pediatrics; 2000 Oct; 106(4):677-83. PubMed ID: 11015508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimate of the potential impact of folic acid fortification of corn masa flour on the prevention of neural tube defects.
    Tinker SC; Devine O; Mai C; Hamner HC; Reefhuis J; Gilboa SM; Dowling NF; Honein MA
    Birth Defects Res A Clin Mol Teratol; 2013 Oct; 97(10):649-57. PubMed ID: 24142499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation influences the distribution of neural tube defect subtypes: A registry-based study.
    Bergman JE; Otten E; Verheij JB; de Walle HE
    Reprod Toxicol; 2016 Jan; 59():96-100. PubMed ID: 26627544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Periconceptional folic acid use prevents both rare and common neural tube defects in China.
    Zhou Y; Crider KS; Yeung LF; Rose CE; Li Z; Berry RJ; Li S; Moore CA
    Birth Defects Res; 2022 Mar; 114(5-6):184-196. PubMed ID: 35098705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neural tube defects: Prevalence, mortality, and maternal characteristics in two departmental hospitals in the northwestern region of Nicaragua, 2006-2018.
    Pastora Bucardo DM; González F; Montes Pastora M; Pimienta Ramirez PA; Bonilla IL; Vielot NA; Finnell RH
    Birth Defects Res; 2023 May; 115(9):945-953. PubMed ID: 37025002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updated estimates of neural tube defects prevented by mandatory folic Acid fortification - United States, 1995-2011.
    Williams J; Mai CT; Mulinare J; Isenburg J; Flood TJ; Ethen M; Frohnert B; Kirby RS;
    MMWR Morb Mortal Wkly Rep; 2015 Jan; 64(1):1-5. PubMed ID: 25590678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long term maintenance of neural tube defects prevention in a high prevalence state.
    Collins JS; Atkinson KK; Dean JH; Best RG; Stevenson RE
    J Pediatr; 2011 Jul; 159(1):143-149.e2. PubMed ID: 21345450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance for anencephaly and spina bifida and the impact of prenatal diagnosis--United States, 1985-1994.
    Cragan JD; Roberts HE; Edmonds LD; Khoury MJ; Kirby RS; Shaw GM; Velie EM; Merz RD; Forrester MB; Williamson RA; Krishnamurti DS; Stevenson RE; Dean JH
    MMWR CDC Surveill Summ; 1995 Aug; 44(4):1-13. PubMed ID: 7637675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supplement use and other characteristics among pregnant women with a previous pregnancy affected by a neural tube defect - United States, 1997-2009.
    Arth A; Tinker S; Moore C; Canfield M; Agopian A; Reefhuis J;
    MMWR Morb Mortal Wkly Rep; 2015 Jan; 64(1):6-9. PubMed ID: 25590679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention program for reducing risk for neural tube defects--South Carolina, 1992-1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1995 Mar; 44(8):141-2. PubMed ID: 7862080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995-2002.
    Williams LJ; Rasmussen SA; Flores A; Kirby RS; Edmonds LD
    Pediatrics; 2005 Sep; 116(3):580-6. PubMed ID: 16140696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spina bifida and anencephaly before and after folic acid mandate--United States, 1995-1996 and 1999-2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 May; 53(17):362-5. PubMed ID: 15129193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Audit of Neural Tube Defects in the Republic Of Ireland for 2012-2015.
    McDonnell R; Delany V; O'Mahony MT; Lynch C; McKeating A; McKeating A; Turner MJ
    Ir Med J; 2018 Mar; 111(3):712. PubMed ID: 30376230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neural tube defect prevalence in California (1990-1994): eliciting patterns by type of defect and maternal race/ethnicity.
    Feuchtbaum LB; Currier RJ; Riggle S; Roberson M; Lorey FW; Cunningham GC
    Genet Test; 1999; 3(3):265-72. PubMed ID: 10495925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural tube defect diagnosis and outcomes at a tertiary South African hospital with intensive case ascertainment.
    Krzesinski EI; Geerts L; Urban MF
    S Afr Med J; 2019 Aug; 109(9):698-703. PubMed ID: 31635597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extremely high prevalence of neural tube defects in a 4-county area in Shanxi Province, China.
    Li Z; Ren A; Zhang L; Ye R; Li S; Zheng J; Hong S; Wang T; Li Z
    Birth Defects Res A Clin Mol Teratol; 2006 Apr; 76(4):237-40. PubMed ID: 16575897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of wheat flour fortification with folic acid on the prevalence of neural tube defects in Chile].
    Nazer H J; Cifuentes O L
    Rev Med Chil; 2013 Jun; 141(6):751-7. PubMed ID: 24121578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival of infants with neural tube defects in the presence of folic acid fortification.
    Bol KA; Collins JS; Kirby RS;
    Pediatrics; 2006 Mar; 117(3):803-13. PubMed ID: 16510661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Periconceptual folic acid intake by Sicilian couples at a risk of recurrence of NTD].
    Pepe F; Pepe P; Grillo S; Insolia G
    Minerva Ginecol; 1999 Oct; 51(10):399-401. PubMed ID: 10638166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.